Industry Focus
Earlier this month, industry watchers gathered at the annual American Society of Clinical Oncology (ASCO) conference to discuss the latest research in the battle against cancer. In today's show, biotech investing expert Brad Loncar shares his key takeaways from the event, including must-hear insight into programs underway at Iovance Biotherapeutics, MacroGenics, and the biotech unicorn, Grail.

Check out more of our content here:

Direct download: 20190612_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST